- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00836329
Improving Neurologic Outcomes in People With Diabetes Who Are Undergoing Heart Surgery
Improving Neurologic Outcomes in Diabetics Undergoing Cardiac Surgery
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
People with diabetes who undergo heart surgery have a greater risk of experiencing a stroke and developing cognitive functioning problems than people without diabetes who undergo heart surgery. There may be a connection between disturbances in glucose metabolism, endothelial dysfunction, and poor neurological outcomes after heart surgery. People with diabetes who receive more intensive blood glucose management during and after heart surgery may have better neurological outcomes than people who control their blood glucose levels in a standard way. The purpose of this study is to evaluate the effectiveness of using a traditional method of controlling blood glucose levels versus a tailored, more intensive method of glucose control on neurological outcomes in people with diabetes who are undergoing heart surgery. Researchers will also examine genetic factors that may be associated with insulin resistance and inflammation.
This study will enroll people undergoing heart surgery. On the day before surgery, participants will undergo a blood collection and neuropsychological testing. They will then be randomly assigned to either a traditional method of blood glucose control or an intensive, tailored method of blood glucose control. Participants following the traditional method of blood glucose control may receive insulin several times a day, based on the results of glucose monitoring. Participants following the intensive, tailored method of blood glucose control will undergo hourly measurements of their glucose levels and receive insulin adjustments as needed to maintain a glucose level of 100-140 mg/dL. During surgery, all participants will undergo an ultrasound of their neck to monitor blood vessel activity. Additional blood samples will be collected during surgery, 6 hours after surgery, 24 hours after surgery, and upon hospital discharge or 5 days after surgery.
One week after surgery or just before leaving the hospital, participants will undergo a magnetic resonance imaging (MRI) procedure and neuropsychological testing. Before leaving the hospital, participants will take part in a diabetes education session and nutrition counseling. Three to 6 weeks and 6 months after surgery, participants will undergo repeat neuropsychological testing. Once a month for 6 months, participants who received the intensive, tailored method of blood glucose control will attend study visits at which time study researchers will monitor their diabetes.
Studietyp
Inskrivning (Faktisk)
Fas
- Fas 3
Kontakter och platser
Studieorter
-
-
North Carolina
-
Winston-Salem, North Carolina, Förenta staterna, 27057
- Wake Forest Baptist Medical Center
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- History of diabetes, elevated fasting blood glucose, elevated hemoglobin A1c, or elevation of these variables during the current hospital admission
- Scheduled to undergo coronary artery bypass graft (CABG) surgery
- Scheduled to undergo aortic valve replacement (AVR), mitral valve replacement (MVR), or both
- Scheduled to undergo valve replacement with CABG
Exclusion Criteria:
- Undergoing emergent (i.e., urgent) procedures
- Alzheimer's disease or similar dementias
- Severe claustrophobia
- Kidney insufficiency, as defined by serum creatine levels greater than 2.0 mg/dL
- Cannot be expected to complete neuropsychological testing
- Recent extensive, life threatening acute myocardial infarction (AMI)
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Intensive Glucose Management
Participants will receive intensive glucose management.
|
Participants in the intensive glucose management group will undergo strict management of their blood glucose levels with a target whole blood glucose level of 100-140 mg/dL preoperatively, intraoperatively, and postoperatively in the intensive care unit (ICU).
Once meals are started, targets for glycemia management will be (a) fasting: 80-140 mg/dL, (b) postprandial: 140-180 mg/dL.
Prior to hospital discharge, participants will receive an in-depth diabetes education session.
After hospital discharge, participants will attend monthly study visits for 6 months so that study researchers can monitor their glycemia management.
|
Aktiv komparator: Traditional Glucose Management
Participants will receive a traditional method of glucose management.
|
Participants will receive traditional management of blood glucose levels while in the hospital.
They may receive insulin several times a day, based on the results of glucose monitoring.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
---|---|
Proportion of participants with identifiable brain lesions detected by magnetic resonance imaging (MRI)
Tidsram: Measured 1 week after surgery
|
Measured 1 week after surgery
|
Proportion of participants with new neuropsychological deficits (20% decline on two or more neuropsychological tests)
Tidsram: Measured 6 months after surgery
|
Measured 6 months after surgery
|
Sekundära resultatmått
Resultatmått |
Tidsram |
---|---|
Number of lesions, as measured by MRI
Tidsram: Measured 1 week after surgery
|
Measured 1 week after surgery
|
Size of lesions, as measured by MRI
Tidsram: Measured 1 week after surgery
|
Measured 1 week after surgery
|
Genetic analysis (i.e., predictive utility of haplotype assignment on primary outcomes)
Tidsram: Measured 6 months after surgery
|
Measured 6 months after surgery
|
Neuropsychological deficits (i.e., predictive utility of neuropsychological performance on presence, number, and volume of lesions)
Tidsram: Measured 6 months after surgery
|
Measured 6 months after surgery
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Edward H. Kincaid, MD, Wake Forest University Health Sciences
- Studierektor: Jorge Calles-Escandon, MD, Wake Forest University Health Sciences
- Studierektor: Donald W. Bowden, PhD, Wake Forest University Health Sciences
- Studierektor: David A. Stump, PhD, Wake Forest University Health Sciences
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 615
- R01HL089115-01 (U.S.S. NIH-anslag/kontrakt)
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Intensive Glucose Management
-
Wake Forest University Health SciencesAvslutadHypertoni SekundärFörenta staterna
-
Wake Forest University Health SciencesHar inte rekryterat ännu
-
Shanghai Jiao Tong University School of MedicineRekrytering
-
Veteran Affairs Office of Patient Care ServicesVA Office of Research and Development; VA Palo Alto Health Care System; VHA...AvslutadPrimärsjukvård | SjukvårdskostnaderFörenta staterna
-
Veteran Affairs Office of Patient Care ServicesVA Office of Research and Development; VA Palo Alto Health Care System; VHA...AvslutadPrimärsjukvård | Sjukvårdskostnader
-
Columbia UniversityMayo Clinic; University of California, Los Angeles; University of Maryland; University of Alabama at Birmingham och andra samarbetspartnersRekryteringKognitiv försämring | Inre halsartärstenosFörenta staterna, Kanada
-
Peking Union Medical College HospitalOkändKronisk sjukdom | KostfiberKina
-
University of ChicagoRekryteringHjärtsvikt | Höger ventrikulär dysfunktion | HögerkammarsviktFörenta staterna
-
Loewenstein HospitalTechnion, Israel Institute of TechnologyRekrytering
-
Riphah International UniversityAvslutad